Crystal Adam

President, R&D at TNGX; Chief Medical Officer at CCCC

Sold, on record
$9.5M
Dollars the filings state
Form 4 sales
19
Latest Sep 1, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • TNGXTango Therapeutics, Inc.President, R&D
  • CCCCC4 Therapeutics, Inc.Chief Medical Officer

Sales by reason

10
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TNGXRoutine
    Mar 25, 2026 2026

    Sold 12,000 shares at $20.11 ($241k)

    Crystal Adam, President, R&D

    10b5-1 planSold 9.6% of holdings ($2.5M position)112,622 shares left0.6x usual sizeFiling

  2. 2 Form 4 sale TNGXRoutine
    Apr 1, 2026 +7 days

    Sold 27,000 shares at $21.20 ($572k)

    Crystal Adam, President, R&D

    10b5-1 planSold 19.3% of holdings ($3M position)112,622 shares left1.5x usual sizeFiling

  3. 3 Form 4 sale TNGXRoutine
    Apr 15, 2026 +14 days

    Sold 38,460 shares at $25.00 ($962k)

    Crystal Adam, President, R&D

    10b5-1 planSold 25.5% of holdings ($3.8M position)112,622 shares left2x usual sizeFiling

  4. 4 Form 4 sale TNGXRoutine
    May 1, 2026 +16 days

    Sold 27,000 shares at $21.22 ($573k)

    Crystal Adam, President, R&D

    10b5-1 planSold 18.9% of holdings ($3M position)115,743 shares left1.3x usual sizeFiling

  5. 5 Form 4 sale TNGXRoutine
    Jun 1, 2026 +31 days

    Sold 27,000 shares at $22.88 ($618k)

    Crystal Adam, President, R&D

    10b5-1 planSold 18.9% of holdings ($3.3M position)115,743 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale TNGXRoutine
    Jul 1, 2026 +30 days

    Sold 27,000 shares at $29.59 ($799k)

    Crystal Adam, President, R&D

    10b5-1 planSold 18.9% of holdings ($4.2M position)115,743 shares left1x usual sizeFiling

  7. 7 Form 4 sale TNGXRoutine
    Aug 3, 2026 +33 days

    Sold 27,000 shares at $27.24 ($736k)

    Crystal Adam, President, R&D

    10b5-1 planSold 18.9% of holdings ($3.9M position)115,743 shares left1x usual sizeFiling

  8. 8 Form 4 sale TNGXRoutine
    Sep 1, 2026 +29 days

    Sold 27,000 shares at $22.37 ($604k)

    Crystal Adam, President, R&D

    10b5-1 planSold 18.9% of holdings ($3.2M position)115,743 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (19)

Form 144 notices and Form 4 sales by Crystal Adam
Source
Sep 1, 2026Sep 3, 2026TNGXPresident, R&DForm 4 sale27,000$604k18.9%RoutineSEC
Aug 3, 2026Aug 5, 2026TNGXPresident, R&DForm 4 sale27,000$736k18.9%RoutineSEC
Jul 1, 2026Jul 2, 2026TNGXPresident, R&DForm 4 sale27,000$799k18.9%RoutineSEC
Jun 1, 2026Jun 3, 2026TNGXPresident, R&DForm 4 sale27,000$618k18.9%RoutineSEC
May 1, 2026May 5, 2026TNGXPresident, R&DForm 4 sale27,000$573k18.9%RoutineSEC
Apr 15, 2026Apr 16, 2026TNGXPresident, R&DForm 4 sale38,460$962k25.5%RoutineSEC
Apr 1, 2026Apr 2, 2026TNGXPresident, R&DForm 4 sale27,000$572k19.3%RoutineSEC
Mar 25, 2026Mar 27, 2026TNGXPresident, R&DForm 4 sale12,000$241k9.6%RoutineSEC
Mar 5, 2026Mar 9, 2026TNGXPresident, R&DForm 4 sale20,251$304k15.2%RoutineSEC
Feb 25, 2026Feb 27, 2026TNGXPresident, R&DForm 4 sale54,345$694k29.0%RoutineSEC
Feb 3, 2026Feb 4, 2026TNGXPresident, R&DForm 4 sale18,452$226k9.0%No planSEC
Feb 5, 2025Feb 6, 2025TNGXOfficerForm 4 sale14,283$44k8.3%No planSEC
Feb 7, 2024Feb 8, 2024TNGXOfficerForm 4 sale8,371$105k6.5%No planSEC
Nov 1, 2023Nov 2, 2023TNGXOfficerForm 4 sale7,507$63k8.5%No planSEC
Jan 4, 2022Jan 5, 2022CCCCChief Medical OfficerForm 4 sale15,000$475k50.0%UnusualSEC
Oct 1, 2021Oct 5, 2021CCCCChief Medical OfficerForm 4 sale15,000$681k100.0%UnusualSEC
Jul 29, 2021Aug 2, 2021CCCCChief Medical OfficerForm 4 sale15,000$675k100.0%UnusualSEC
Jul 1, 2021Jul 6, 2021CCCCChief Medical OfficerForm 4 sale15,000$570k100.0%UnusualSEC
Apr 5, 2021Apr 6, 2021CCCCChief Medical OfficerForm 4 sale15,000$567k100.0%UnusualSEC